A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells

  • Matthew Mahoney
  • , Vishnu C. Damalanka
  • , Michael A. Tartell
  • , Dong hee Chung
  • , Andre Luiz Lourenço
  • , Dustin Pwee
  • , Anne E. Mayer Bridwell
  • , Markus Hoffmann
  • , Jorine Voss
  • , Partha Karmakar
  • , Nurit P. Azouz
  • , Andrea M. Klingler
  • , Paul W. Rothlauf
  • , Cassandra E. Thompson
  • , Melody Lee
  • , Lidija Klampfer
  • , Christina L. Stallings
  • , Marc E. Rothenberg
  • , Stefan Pohlmann
  • , Sean P.J. Whelan
  • Anthony J. O’Donoghue, Charles S. Craik, James W. Janetka

Research output: Contribution to journalArticlepeer-review

94 Scopus citations

Fingerprint

Dive into the research topics of 'A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science